Octreotide for injectable suspension; Good manufacturing practices concerns
In plain language
This recall involves Octreotide for injectable suspension sold in Canada by Teva Canada Limited. It's being recalled due to quality concerns related to manufacturing practices. Stop using the product and speak to your healthcare professional for an alternative.
What to do
- Stop using the product immediately.
- Speak to your healthcare professional for an alternative or replacement.
- Return affected products to the pharmacy for proper disposal.
- Seek medical attention if you have used this product and have symptoms of infection or other unexpected symptoms.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Octreotide for injectable suspension 10 mg/vial
Lot: 4401203R, 4401202, 4400915
Octreotide for injectable suspension 20 mg/vial
Lot: 4501460, 4401309, 4401501, 4401231, 4401065
Octreotide for injectable suspension 30 mg/vial
Lot: 4501296, 4401394, 4500804, 4500219, 4401208, 4500218, 4401207, 4400955, 4400918
Why this matters
Product quality concerns
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 4401203R, 4401202, 4400915, 4501296, 4401394, 4500804, 4500219, 4401208, 4500218, 4401207, 4400955, 4400918, 4501460, 4401309, 4401501, 4401231, 4401065
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Product quality concerns
What should consumers do?
Stop using the product immediately. Speak to your healthcare professional for an alternative or replacement. Return affected products to the pharmacy for proper disposal. Seek medical attention if you have used this product and have symptoms of infection or other unexpected symptoms.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Product quality concerns
When was this product recalled?
This product was recalled on January 13, 2026.
Is the Teva Canada Limited brand affected by this recall?
Yes, Teva Canada Limited products are affected by this recall. This recall involves Octreotide for injectable suspension sold in Canada by Teva Canada Limited. It's being recalled due to quality concerns related to manufacturing practices. Stop using the product and speak to your healthcare professional for an alternative.